Powered by

Bind Therapeutics estate heading for confirmation

Aug 16, 2016 - The Deal Pipeline

The estate of cancer treatment developer Bind Therapeutics Inc. has filed a liquidation plan for a wind-down of the company that would pay all creditors in full following the sale of its assets to drugmaker Pfizer Inc. (PFE) for $40 million.

The Cambridge, Mass., debtor, which changed its name to DNIB Unwind Inc. on Aug. 1, submitted the plan and related disclosure statement on Monday, Aug. 15, in the U.S. Bankruptcy Court for the District of Delaware in Wilmington.

Chief Judge ...